ES2058874T3 - 1-acil-2-pirrolidinonas como mejoradores del entendimiento y memoria y composiciones farmaceuticas que las contienen. - Google Patents

1-acil-2-pirrolidinonas como mejoradores del entendimiento y memoria y composiciones farmaceuticas que las contienen.

Info

Publication number
ES2058874T3
ES2058874T3 ES90830256T ES90830256T ES2058874T3 ES 2058874 T3 ES2058874 T3 ES 2058874T3 ES 90830256 T ES90830256 T ES 90830256T ES 90830256 T ES90830256 T ES 90830256T ES 2058874 T3 ES2058874 T3 ES 2058874T3
Authority
ES
Spain
Prior art keywords
acil
memory
pharmaceutical compositions
reduced
pirrolidinonas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90830256T
Other languages
English (en)
Inventor
Fabio Giannessi
Orlando Ghirardi
Domenico Misiti
Maria Ornella Tinti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of ES2058874T3 publication Critical patent/ES2058874T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

PIRROLIDINONES-2-ACIL-1 DE FORMULA GENERAL (I) EN DONDE R ESTA SELECCIONADO DEL GRUPO QUE CONSTA DE : FENIL SUSTITUIDO CON ALQUIL (C1-C4)REDUCIDO SUSTITUIDO DE HALOGENO; FENILALQUIL, EN DONDE LA PARTE ALQUIL TIENE 2-4 CARBONOS; FENILALQUENIL, EN DONDE LA PARTE ALQUENIL TIENE 2-4 CARBONOS Y LA PARTE FENIL ES SUSTITUIDA CON ALQUIL (C1-C4)REDUCIDO SUSTITUIDO DE HALOGENO; PIRROLIDIN-2-IL SUSTITUIDO-N; Y PIRID-3-IL SON INCREMENTADORES POTENTES DEL APRENDIZAJE Y MEMORIA. LAS COMPOSICIONES FARMACEUTICAS ADMINISTRABLES ORAL O PARENTERALMENTE EN LA FORMA DE DOSIS UNIDAD, COMPRENDE DE SOBRE 100 A 500 MG DE UNO DE LOS COMPONENTES DE LA FORMULA (I).
ES90830256T 1989-06-12 1990-06-08 1-acil-2-pirrolidinonas como mejoradores del entendimiento y memoria y composiciones farmaceuticas que las contienen. Expired - Lifetime ES2058874T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8948072A IT1231921B (it) 1989-06-12 1989-06-12 1-acil-2-pirrolidoni quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti

Publications (1)

Publication Number Publication Date
ES2058874T3 true ES2058874T3 (es) 1994-11-01

Family

ID=11264356

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90830256T Expired - Lifetime ES2058874T3 (es) 1989-06-12 1990-06-08 1-acil-2-pirrolidinonas como mejoradores del entendimiento y memoria y composiciones farmaceuticas que las contienen.

Country Status (8)

Country Link
US (1) US5102896A (es)
EP (1) EP0412058B1 (es)
JP (1) JPH0324054A (es)
AT (1) ATE110363T1 (es)
DE (1) DE69011781T2 (es)
DK (1) DK0412058T3 (es)
ES (1) ES2058874T3 (es)
IT (1) IT1231921B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1247698B (it) * 1990-06-21 1994-12-30 Sigma Tau Ind Farmaceuti 1-alchil-3-(acilammino)-e-caprolattami quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
IT1249728B (it) * 1991-11-06 1995-03-09 Sigma Tau Ind Farmaceuti Derivati delle prolinammide quali attivatori della memoria e dei processi di apprendimento e composizioni farmaceutiche che li contengono
NZ255097A (en) * 1992-07-24 2001-04-27 Univ California Heterocyclic derivatives (such as 1-(1,4-bgenzodioxan-5-ylcarbonyl)-1,2,3,6-tetrahydropyridine) and medicaments that enhance synaptic responses
EP0730631B1 (en) * 1993-11-25 1999-07-07 WARWICK INTERNATIONAL GROUP LIMITED (Company No. 2982784) Bleaching compositions
CA2165919A1 (en) * 1994-12-26 1996-06-27 Koichi Katsuyama Agents for inhibiting the production of il-1.beta. and the release of tnf.
CN103910712B (zh) * 2014-04-02 2016-09-07 江南大学 一种过氧化氢活化剂及其应用
CN104032563B (zh) * 2014-05-27 2016-03-23 浙江莱美纺织印染科技有限公司 一种涤纶混纺织物漂白前处理方法
US11878971B2 (en) 2020-12-29 2024-01-23 Huscion Co., Ltd. Piperlongumine-based compound and immuno regulator comprising the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1115212A (en) * 1978-02-10 1981-12-29 Emilio Kyburz Pyrrolidine derivatives
CU21107A3 (es) * 1978-02-10 1988-02-01 Hoffmann La Roche Pyrrolidines derivatives
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
JPS61229801A (ja) * 1985-04-03 1986-10-14 Taki Chem Co Ltd 植物生長調節剤

Also Published As

Publication number Publication date
JPH0324054A (ja) 1991-02-01
DE69011781D1 (de) 1994-09-29
EP0412058B1 (en) 1994-08-24
IT8948072A0 (it) 1989-06-12
ATE110363T1 (de) 1994-09-15
EP0412058A1 (en) 1991-02-06
IT1231921B (it) 1992-01-15
DE69011781T2 (de) 1995-01-05
DK0412058T3 (da) 1994-09-19
US5102896A (en) 1992-04-07

Similar Documents

Publication Publication Date Title
CL2003002756A1 (es) Compuestos derivados de (1-carbamoil-1,1-defenilmetil)-1-[substituido)alquil]purrolidinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del sindrome de intestino irritable o incontinencia.
ES2040838T3 (es) Compuestos piperazinil-heterociclicos.
ES2191048T3 (es) Derivados de oxazolidinona y compuestos farmaceuticos que los contienen.
DE69325130D1 (de) N-sulfonyl-2-oxoindol-derivate mit einer affinität für die vasopressin und/oder ocytocin rezeptoren
AR025225A1 (es) Feniloxazolidinonas heterociclicas biciclicas sustituidas antibacterianas y composiciones farmacéuticas
ES2180530T3 (es) Sulfonamidas de tiofeno utiles como inhibidores de anhidrasa carbonica.
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
MX9300786A (es) Compuestos hipolipidaemicos.
ES2118203T3 (es) Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
AR005672A1 (es) Derivados de la distamicina, proceso para prepararlos, y su utilizacion como agentes antitumorales y antivirales.
ES2045044T3 (es) Derivados de sulfonamidolfenilo y agentes terapeuticos y preventivos de la arritmia que contienen los mismos.
ES2058874T3 (es) 1-acil-2-pirrolidinonas como mejoradores del entendimiento y memoria y composiciones farmaceuticas que las contienen.
ES2098023T3 (es) Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen.
ES452200A1 (es) Un procedimiento para la preparacion de nuevos derivados de pipendina.
ES2163399T3 (es) Derivados de neolignano como antagonistas receptores del factor de activacion de plaquetas e inhibidores 5-lipooxigenasa.
ES2070002T3 (es) Composiciones terapeuticas a base de derivados de 1,2-ditiol-3-tiona.
SE8302979D0 (sv) Piperazine derivatives, their production and pharmaceutical compositions containing them
ES2084740T3 (es) Derivados de diamino-5-triazinona y composiciones polimericas autoextinguentes que los contienen.
SE8305157L (sv) Biologiskt aktiva 2,5-piperazindionderivat, sett for framstellning derav samt farmaceutiska kompositioner innehallande desamma
ES2119874T3 (es) Nuevos derivados de elipticina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
SE8306225D0 (sv) 2-piperazinyl-quinazoline derivatives, their production and pharmaceutical compositions containing them
AR002749A1 (es) Derivados de estiril bencimidazol y composicion farmaceutica que los comprende.
ES2081463T3 (es) 1-alquil-3-(acilamino)-epsilon-caprolactamas como mejoradores del aprendimiento y memoria y composiciones farmaceuticas que las contienen.
ES2104174T3 (es) Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos.
MX9203234A (es) Derivados de 5-halovinil-2-desoxiuridina y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 412058

Country of ref document: ES